NECLIFE — Nectar Lifesciences Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareSpeculativeMicro CapValue Trap

Annual balance sheet for Nectar Lifesciences, fiscal year end - March 31st, INR millions except per share, conversion factor applied.

	R2021 March 31st	2022 March 31st	2023 March 31st	2024 March 31st	2025 March 31st
Period Length:	—	—	—	—	—
Source:	ARS	ARS	ARS	ARS	PRESS
Standards:	IAS	IAS	IAS	IAS	—
Status:	Final	Final	Final	Final	Final
Cash
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	243	162	179	203	273
Net Total Accounts Receivable
Net Total Receivables	5,522	6,107	4,450	4,822	3,463
Total Inventory
Total Other Current Assets
Total Current Assets	12,388	13,548	12,312	12,838	12,376
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	8,322	7,652	6,904	6,561	6,333
Net Intangible Assets
Long Term Investments
Long Term Notes Receivable
Other Long Term Assets
Total Assets	23,881	23,908	21,892	21,911	20,472
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	11,874	10,038	8,909	9,728	10,215
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Funded Status
Total Liabilities	13,261	13,029	11,246	11,218	10,911
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	10,620	10,879	10,646	10,692	9,561
Total Liabilities & Shareholders' Equity	23,881	23,908	21,892	21,911	20,472
Total Common Shares Outstanding